Spectrum Pharma (SPPI) Tops Q4 EPS by 17c

Spectrum Pharma (NASDAQ: SPPI) reported Q4 EPS of ($0.10), $0.17 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $32.2 million versus the consensus estimate of $31.13 million.

For earnings history and earnings-related data on Spectrum Pharma (SPPI) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• XP Inc. (XP) Tops Q2 EPS by 8c
• Aon names interim CFO as Edmund Reese exits the firm